13F HOLDINGS REPORT
Avidity Partners Management LP
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001791827-24-000004
Total Value
$3.10B
Positions
90
Other Managers
0
Confidential Omitted
No
Holdings (90)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 600,000 | $239.5M | 7.72% |
| 2 | FUSION PHARMACEUTICALS INC | 36118A100 | 6,500,328 | $138.6M | 4.47% |
| 3 | BOSTON SCIENTIFIC CORP | BSX | 1,956,000 | $134.0M | 4.32% |
| 4 | ARVINAS INC | ARVN | 2,985,190 | $123.2M | 3.97% |
| 5 | INTUITIVE SURGICAL INC | ISRG | 226,000 | $90.2M | 2.91% |
| 6 | DIANTHUS THERAPEUTICS INC | DNTH | 2,717,554 | $81.5M | 2.63% |
| 7 | ACADIA HEALTHCARE COMPANY IN | ACHC | 1,005,000 | $79.6M | 2.57% |
| 8 | NEUROCRINE BIOSCIENCES INC | NBIX | 536,500 | $74.0M | 2.39% |
| 9 | NATERA INC | NTRA | 803,300 | $73.5M | 2.37% |
| 10 | JAZZ PHARMACEUTICALS PLC | JAZZ | 584,000 | $70.3M | 2.27% |
| 11 | AVANTOR INC | AVTR | 2,695,000 | $68.9M | 2.22% |
| 12 | THE CIGNA GROUP | 125523100 | 184,500 | $67.0M | 2.16% |
| 13 | MERCK & CO INC | MRK | 502,000 | $66.2M | 2.14% |
| 14 | REGENERON PHARMACEUTICALS | REGN | 68,000 | $65.4M | 2.11% |
| 15 | CG ONCOLOGY INC | CGON | 1,454,765 | $63.9M | 2.06% |
| 16 | ILLUMINA INC | ILMN | 464,100 | $63.7M | 2.05% |
| 17 | TENET HEALTHCARE CORP | THC | 601,000 | $63.2M | 2.04% |
| 18 | ALIGN TECHNOLOGY INC | ALGN | 189,000 | $62.0M | 2.00% |
| 19 | SYNDAX PHARMACEUTICALS INC | SNDX | 2,412,500 | $57.4M | 1.85% |
| 20 | ELI LILLY & CO | LLY | 70,000 | $54.5M | 1.76% |
| 21 | UNITED THERAPEUTICS CORP DEL | UTHR | 217,000 | $49.8M | 1.61% |
| 22 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 1,174,700 | $46.6M | 1.50% |
| 23 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 933,500 | $43.6M | 1.41% |
| 24 | CVS HEALTH CORP | CVS | 545,000 | $43.5M | 1.40% |
| 25 | SURGERY PARTNERS INC | SGRY | 1,445,000 | $43.1M | 1.39% |
| 26 | CYTOKINETICS INC | CYTK | 600,000 | $42.1M | 1.36% |
| 27 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 600,000 | $41.5M | 1.34% |
| 28 | ABBVIE INC | ABBV | 227,000 | $41.3M | 1.33% |
| 29 | BLUEPRINT MEDICINES CORP | 09627Y109 | 426,000 | $40.4M | 1.30% |
| 30 | LEGEND BIOTECH CORP | LEGN | 668,300 | $37.5M | 1.21% |
| 31 | STRUCTURE THERAPEUTICS INC | GPCR | 864,000 | $37.0M | 1.19% |
| 32 | ALNYLAM PHARMACEUTICALS INC | ALNY | 243,000 | $36.3M | 1.17% |
| 33 | DANAHER CORPORATION | 235851102 | 143,800 | $35.9M | 1.16% |
| 34 | IDEAYA BIOSCIENCES INC | IDYA | 799,700 | $35.1M | 1.13% |
| 35 | AXSOME THERAPEUTICS INC | AXSM | 431,000 | $34.4M | 1.11% |
| 36 | XENON PHARMACEUTICALS INC | XENE | 710,000 | $30.6M | 0.99% |
| 37 | LANTHEUS HLDGS INC | LNTH | 480,000 | $29.9M | 0.96% |
| 38 | CARIBOU BIOSCIENCES INC | CRBU | 5,785,352 | $29.7M | 0.96% |
| 39 | MIRUM PHARMACEUTICALS INC | MIRM | 1,142,850 | $28.7M | 0.93% |
| 40 | ROCKET PHARMACEUTICALS INC | RCKTW | 1,025,000 | $27.6M | 0.89% |
| 41 | REGENXBIO INC | RGNX | 1,300,064 | $27.4M | 0.88% |
| 42 | APOGEE THERAPEUTICS INC | APGE | 384,893 | $25.6M | 0.82% |
| 43 | NEUMORA THERAPEUTICS INC. | NMRA | 1,800,000 | $24.8M | 0.80% |
| 44 | DEXCOM INC | DXCM | 176,900 | $24.5M | 0.79% |
| 45 | NEUROGENE INC | NGNE | 465,237 | $23.7M | 0.76% |
| 46 | JASPER THERAPEUTICS INC | JSPRW | 760,000 | $22.3M | 0.72% |
| 47 | IMMUNOME INC | IMNM | 873,891 | $21.6M | 0.70% |
| 48 | THERMO FISHER SCIENTIFIC INC | TMO | 36,600 | $21.3M | 0.69% |
| 49 | GLAUKOS CORP | GKOS | 224,000 | $21.1M | 0.68% |
| 50 | REVOLUTION MEDICINES INC | RVMDW | 635,000 | $20.5M | 0.66% |
| 51 | VAXCYTE INC | PCVX | 284,000 | $19.4M | 0.63% |
| 52 | IMMUNOCORE HLDGS PLC | IMCR | 286,400 | $18.6M | 0.60% |
| 53 | PHATHOM PHARMACEUTICALS INC | PHAT | 1,735,000 | $18.4M | 0.59% |
| 54 | MCKESSON CORP | MCK | 33,300 | $17.9M | 0.58% |
| 55 | VERA THERAPEUTICS INC | VERA | 383,500 | $16.5M | 0.53% |
| 56 | IMMUNOVANT INC | IMVT | 505,000 | $16.3M | 0.53% |
| 57 | PRIVIA HEALTH GROUP INC | PRVA | 764,200 | $15.0M | 0.48% |
| 58 | JANUX THERAPEUTICS INC | JANX | 384,245 | $14.5M | 0.47% |
| 59 | CYBIN INC | HELP | 34,884,000 | $14.4M | 0.47% |
| 60 | COLLEGIUM PHARMACEUTICAL INC | COLL | 361,400 | $14.0M | 0.45% |
| 61 | PRIME MEDICINE INC | PRME | 1,990,000 | $13.9M | 0.45% |
| 62 | KEROS THERAPEUTICS INC | KROS | 209,700 | $13.9M | 0.45% |
| 63 | ASTRIA THERAPEUTICS INC | 04635X102 | 982,000 | $13.8M | 0.45% |
| 64 | AC IMMUNE SA | ACIU | 4,470,000 | $13.2M | 0.43% |
| 65 | KARYOPHARM THERAPEUTICS INC | KPTI | 8,298,570 | $12.5M | 0.40% |
| 66 | IMMUNIC INC | IMUX | 8,902,972 | $11.8M | 0.38% |
| 67 | CYTOKINETICS INC | CYTK | 166,000 | $11.6M | 0.38% |
| 68 | RADNET INC | RDNT | 238,000 | $11.6M | 0.37% |
| 69 | ESTABLISHMENT LABS HLDGS INC | ESTA | 225,000 | $11.5M | 0.37% |
| 70 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 475,000 | $11.2M | 0.36% |
| 71 | ACADIA PHARMACEUTICALS INC | ACAD | 588,500 | $10.9M | 0.35% |
| 72 | ASTRAZENECA PLC | AZN | 160,000 | $10.8M | 0.35% |
| 73 | SYROS PHARMACEUTICALS INC | 87184Q206 | 1,673,538 | $9.0M | 0.29% |
| 74 | STRUCTURE THERAPEUTICS INC | GPCR | 150,000 | $6.4M | 0.21% |
| 75 | IONIS PHARMACEUTICALS INC | IONS | 130,000 | $5.6M | 0.18% |
| 76 | CENTURY THERAPEUTICS INC | IPSC | 1,221,555 | $5.1M | 0.16% |
| 77 | KYVERNA THERAPEUTICS INC | KYTX | 202,333 | $5.0M | 0.16% |
| 78 | EMERGENT BIOSOLUTIONS INC | EBS | 1,908,000 | $4.8M | 0.16% |
| 79 | KEZAR LIFE SCIENCES INC | KZR | 5,026,000 | $4.5M | 0.15% |
| 80 | BIOHAVEN LTD | BHVN | 75,000 | $4.1M | 0.13% |
| 81 | AN2 THERAPEUTICS INC | ANTX | 1,150,000 | $3.7M | 0.12% |
| 82 | GINKGO BIOWORKS HOLDINGS INC | DNABW | 3,000,000 | $3.5M | 0.11% |
| 83 | X4 PHARMACEUTICALS INC | XFOR | 2,413,000 | $3.4M | 0.11% |
| 84 | COGENT BIOSCIENCES INC | COGT | 445,706 | $3.0M | 0.10% |
| 85 | PACIFIC BIOSCIENCES CALIF IN | 69404D108 | 675,000 | $2.5M | 0.08% |
| 86 | SCYNEXIS INC | SCYX | 1,448,728 | $2.1M | 0.07% |
| 87 | KODIAK SCIENCES INC | KOD | 300,000 | $1.6M | 0.05% |
| 88 | HYPERFINE INC | HYPR | 1,188,178 | $1.2M | 0.04% |
| 89 | CAREMAX INC | 14171W202 | 21,200 | $102,184 | 0.00% |
| 90 | NUVATION BIO INC | NUVB | 89,543 | $27,087 | 0.00% |